Skip to main content

Melagenina

Volume 131: debated on Thursday 14 April 1988

The text on this page has been created from Hansard archive content, it may contain typographical errors.

To ask the Secretary of State for Social Services if he will provide the necessary funding for testing the effectiveness of melagenina in the treatment of vitiligo.

No. Any medicinal product such as this lotion must be subject to a product licence before it may be marketed in the United Kingdom. Applicants for product licences need to supply sufficient data to the licensing authority to enable them to assess the products safety, quality and efficacy.